Zhu, Y.; Tang, R.; Li, X.; Chen, X.; Wang, X.; Wang, Y.; Wang, R.; Zhu, F.; Li, J.
Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine as the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical Trial. Vaccines 2024, 12, 292.
https://doi.org/10.3390/vaccines12030292
AMA Style
Zhu Y, Tang R, Li X, Chen X, Wang X, Wang Y, Wang R, Zhu F, Li J.
Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine as the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical Trial. Vaccines. 2024; 12(3):292.
https://doi.org/10.3390/vaccines12030292
Chicago/Turabian Style
Zhu, Yawen, Rong Tang, Xiaolong Li, Xiaoqin Chen, Xue Wang, Ying Wang, Ruijie Wang, Fengcai Zhu, and Jingxin Li.
2024. "Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine as the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical Trial" Vaccines 12, no. 3: 292.
https://doi.org/10.3390/vaccines12030292
APA Style
Zhu, Y., Tang, R., Li, X., Chen, X., Wang, X., Wang, Y., Wang, R., Zhu, F., & Li, J.
(2024). Vaccination with Adenovirus Type 5 Vector-Based COVID-19 Vaccine as the Primary Series in Adults: A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Clinical Trial. Vaccines, 12(3), 292.
https://doi.org/10.3390/vaccines12030292
